Is OrganiGram Holdings Inc (OTCMKTS:OGRMF) a Giant in the Making?

Is OrganiGram Holdings Inc (OTCMKTS:OGRMF) a Giant in the Making?

SHARE

Late last month, we expressed conviction that OrganiGram Holdings Inc (OTCMKTS:OGRMF) would be one of the most impressive outperformers in the cannabis run this fall because it was underappreciated in terms of its second-derivative growth potential – essentially moving from a small player in the space to one of the players with the capacity to survive and thrive in a post-consolidation world for cannabis producers (one that will be with us before long).

To help reinforce this point, the company just announced that it has chosen to include its award-winning sativa flower, Wabanaki, in the AHLOT Cannabis Collections: Discovery Series Vol. 1™. According to the release, “The product, the first of its kind in the world, will contain five one-gram bottles of high-quality cannabis sourced from a hand-picked group of Canadian licensed producers. The variety pack has been selected for distribution by the Ontario Cannabis Store and will be available to consumers following the launch of the adult recreational market on Oct. 17.”

OrganiGram Holdings Inc (OTCMKTS:OGRMF) casts itself as a company that produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.

According to company materials, OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition-specific medical marijuana for patients in Canada.

OGRMF’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.

According to company materials, “From the day we started back in 2013, it’s been about making lives better – for our clients, our people, and our community. We’re based in Moncton, New Brunswick, the heart of the Maritimes, but at OrganiGram Holdings we’re committed to improving the quality of life for Canadians across the country. For us, this means working with health-care providers and industry organizations, supporting research and education, and providing a safe, effective product. To be effective in that last goal, we made a decision to produce organic cannabis. Growing certified organic medical cannabis isn’t easy, in fact, most licensed producers won’t take this on. It means more care, more testing, more rules… but in the end, it means a product that we feel delivers on our goals in the best way. And improving the quality of life for Canadians is not just about getting safe, quality product to them effectively. It’s about creating jobs, being good neighbors and contributing to our community.”

Find out when $OGRMF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, the company just announced that it has chosen to include its award-winning sativa flower, Wabanaki, in the AHLOT Cannabis Collections. Shares continue to break higher, with recent action showing 72% tacked on for the stock in the past month. Furthermore, the company has benefitted from a jump in recent trading volume to the tune of exceeding 330% over what the stock has registered over the longer term.

“We are thrilled to have an award-winning Organigram flower included in this offering,” says AHLOT Chief Executive Officer, Greg Pantelic. “It may be difficult for consumers to distinguish between brands and to determine which brands are right for them upon the launch of the adult recreational market. Introducing product to consumers will help set the stage for defining high-quality cannabis in this exciting new legal market.”

Now commanding a market cap of $753.12M, OGRMF has a significant war chest ($31.6M) of cash on the books, which stands against about $9.1M in total current liabilities. OGRMF is pulling in trailing 12-month revenues of $12.2M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 94.3%. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $OGRMF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $OGRMF, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter